Alzheimer's disease (AD) represents a significant unmet medical need and a growing global health challenge.
The ID/AD initiative – Identify (ID) Alzheimer’s Disease (AD) aims to raise awareness of Alzheimer’s disease early signs and symptoms and the importance of accurate diagnosis for timely brain health interventions.
A better understanding of the early stages of Alzheimer's disease is opening up opportunities for timely detection, diagnosis and interventions.
Early detection of mild cognitive impairment provides an opportunity to identify one of the causes - Alzheimer’s disease in the pre-dementia stage.
Collaboration among all stakeholders is required to improve Alzheimer's prevention, diagnosis, and care.
Close collaboration between primary and specialized care is needed to improve Alzheimer's disease management.
Lifestyle interventions, including social and cognitive activity, may help preserve brain health.
Policy leadership and commitment is needed in Alzheimer's disease to optimise quality of care and support for patients, their care partners and families.
Find useful resources for clinical practice including links to journal articles, selected information on Alzheimer's disease, strategies for patient engagement and insights into AD health research initiatives.
1.Alzheimer’s Association. 2021 Alzheimer’s Disease Facts and Figures. Alzheimers Dement 2021;17(3).
2.Petersen RC. Mild cognitive impairment. Continuum (Minneap Minn). 2016;22(2):404-418.
3.Dubois B, Padovani A, Scheltens P, et al. Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges. J Alzheimers Dis. 2016;49(3):617-31.